Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on: April 28,2024

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on:April 28,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on: February 23,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on:February 23,2024

Genetic variation linked to cognitive differences after radiation for pediatric medulloblastoma

by Emory UniversityAlthough clinicians have aimed at reducing doses of radiotherapy to lessen long-term impairment in medulloblastoma patients, research thus far has shown that lower doses lead t

Updated on: May 13,2024

Genetic variation linked to cognitive differences after radiation for pediatric medulloblastoma

by Emory UniversityAlthough clinicians have aimed at reducing doses of radiotherapy to lessen long-term impairment in medulloblastoma patients, research thus far has shown that lower doses lead t

Updated on:May 13,2024

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on: May 27,2024

Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl

Updated on:May 27,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on: April 22,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on:April 22,2024

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on: May 21,2024

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on:May 21,2024

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has

Updated on: January 23,2024

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has

Updated on:January 23,2024

Two drugs are better than one in fight against leukaemia

by FreshscienceDr Laura Eadie at work in the SAHMRI Leukaemia Research Laboratory. Credit: SAHMRIAdelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatm

Updated on: April 20,2024

Two drugs are better than one in fight against leukaemia

by FreshscienceDr Laura Eadie at work in the SAHMRI Leukaemia Research Laboratory. Credit: SAHMRIAdelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatm

Updated on:April 20,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on: March 09,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on:March 09,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on: August 03,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on:August 03,2024

A deep-learning model may help predict lung cancer survival and outcomes

by American Association for Cancer ResearchLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA deep-learning model developed using serial image scans of tumors from p

Updated on: May 20,2024

A deep-learning model may help predict lung cancer survival and outcomes

by American Association for Cancer ResearchLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA deep-learning model developed using serial image scans of tumors from p

Updated on:May 20,2024